Martin Leblanc
President, CEO and Director
Biotechnology
Caprion Proteomics
United States of America
Biography
Mr. Martin LeBlanc has been President of Caprion Proteomics since 2007 and serves as its Chief Executive Officer. Mr. LeBlanc successfully led and negotiated the sale and recapitalization of Caprion's Proteomics to Great Point Partners LLC in July 2007, as well the equity investment and strategic distribution alliance with Covance Inc., concluded in December 2008. His featured skills and endorsements include biotechnology,technology transfer and life sciences
Research Interest
Biotechnology